Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Clinical trial NCT02330965 · COMPLETED
Trial details
- NCT number
- NCT02330965
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-07-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.